Bering HA - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Page 1

GM-CSF as an alternative to dose modification of the combination zidovudine and interferon-alpha in the treatment of AIDS-associated Kaposi's sarcoma.

Scadden DT, Bering HA, Levine JD, Bresnahan J, Evans L, Epstein C, Groopman JE. Scadden DT, et al. Among authors: bering ha. Am J Clin Oncol. 1991;14 Suppl 1:S40-4. doi: 10.1097/00000421-199112001-00008. Am J Clin Oncol. 1991. PMID: 2048563 Clinical Trial.

Granulocyte-macrophage colony-stimulating factor mitigates the neutropenia of combined interferon alfa and zidovudine treatment of acquired immune deficiency syndrome-associated Kaposi's sarcoma.

Scadden DT, Bering HA, Levine JD, Bresnahan J, Evans L, Epstein C, Groopman JE. Scadden DT, et al. Among authors: bering ha. J Clin Oncol. 1991 May;9(5):802-8. doi: 10.1200/JCO.1991.9.5.802. J Clin Oncol. 1991. PMID: 2016623 Clinical Trial.

A phase I study of an outpatient regimen of recombinant human interleukin-2 and alpha-2a-interferon in patients with solid tumors.

Huberman M, Bering H, Fallon B, Tessitore J, Sonnenborn H, Paul S, Zeffren J, Levitt D, Groopman J. Huberman M, et al. Cancer. 1991 Oct 15;68(8):1708-13. doi: 10.1002/1097-0142(19911015)68:8<1708::aid-cncr2820680810>3.0.co;2-v. Cancer. 1991. PMID: 1913512 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3 results

Search Page

Filters